AC
UTHR icon

Allstate Corporation’s United Therapeutics UTHR Stock Holding History

Allstate Corporation’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Sell
3,453
-1,257
-27% -$708K 0.02% 495
2026
Q1 		$2.79M Buy
4,710
+1,615
+52% +$804K 0.03% 396
2025
Q4 		$1.51M Buy
3,095
+1,631
+111% +$760K 0.02% 435
2025
Q3 		$614K Buy
+1,464
New +$492K 0.01% 477
2025
Q2 		– Sell
-1,930
Closed -$595K – 544
2025
Q1 		$595K Buy
1,930
+754
+64% +$258K 0.02% 472
2024
Q4 		$415K Buy
+1,176
New +$432K 0.01% 529
2017
Q3 		– Sell
-6,111
Closed -$793K – 246
2017
Q2 		$793K Buy
+6,111
New +$762K 0.04% 267

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Allstate Corporation's UTHR Position: Q2 2026 in Review

Allstate Corporation reduced its United Therapeutics (UTHR) stake by 27% in Q2 2026, selling an estimated $708K and leaving 3,453 shares worth $1.87M. The position accounts for 0.02% of the portfolio, ranked #495.

Allstate Corporation first reported a position in UTHR in Q2 2017 and has held it in 7 quarters since. The position peaked at $2.79M in Q1 2026. 882 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Allstate Corporation held 3,453 shares of United Therapeutics worth $1.87M as of Q2 2026.
  • Allstate Corporation sold 1,257 United Therapeutics shares in Q2 2026, an estimated $708K.
  • United Therapeutics made up 0.02% of Allstate Corporation's portfolio in Q2 2026, its #495 holding.
  • Allstate Corporation first reported a position in United Therapeutics in Q2 2017 and has held it in 7 quarters since.
  • Allstate Corporation's United Therapeutics position peaked at $2.79M in Q1 2026.
  • 882 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.